v3.23.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 2,042,741 $ 3,191,714
Short-term investments 4,167,755 35,837,309
Accounts receivable 313,906 81,456
Grant receivable   1,524,522
Prepaid expenses and other current assets 1,261,228 1,491,123
Current assets held for sale 16,394,533 7,928,136
Total Current Assets 24,180,163 50,054,260
Property and Equipment, net 18,683,898 20,438,521
Operating lease right-of-use asset 5,346,910 5,866,261
Finance lease right-of-use asset 20,979,923 15,329,075
Other assets 453,135 260,011
Deposits 271,115 270,461
Non-current assets held for sale   12,178,323
Total Assets 69,915,144 104,396,912
Current Liabilities    
Accounts payable 2,873,696 4,213,732
Deferred revenue, current portion 4,056,646 1,585,808
Operating lease liability, current portion 404,566 397,855
Finance lease liability, current portion 895,625 301,048
Accrued expenses and other liabilities 2,031,618 1,916,601
Current liabilities held for sale 14,225,696 9,622,279
Total Current Liabilities 24,487,847 18,037,323
Long Term Liabilities    
Deferred revenue, net of current portion 32,500 32,500
Operating lease liability, net of current portion 2,825,536 3,079,887
Financing lease liability, net of current portion 9,122,617 5,520,034
Non-current liabilities held for sale   5,290,500
Total Liabilities 36,468,500 31,960,244
Commitments and Contingencies (Note 13 and Note 14)
Stockholders' Equity    
Common stock, $0.0002 par value; 250,000,000 shares authorized, 26,081,890 and 25,661,488 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 5,217 5,126
Additional paid-in capital 285,090,202 283,019,456
Accumulated deficit (248,962,791) (209,153,659)
Accumulated other comprehensive income 159,929 51,924
Total Stockholders' Equity - NightHawk Biosciences, Inc. 36,292,557 73,922,847
Non-Controlling Interest (2,845,913) (1,486,179)
Total Stockholders' Equity 33,446,644 72,436,668
Total Liabilities and Stockholders' Equity $ 69,915,144 $ 104,396,912

Source